Increased lysophosphatidylcholine content in lesional psoriatic skin
AK Ryborg, B Grøn, K Kragballe - British Journal of …, 1995 - Wiley Online Library
AK Ryborg, B Grøn, K Kragballe
British Journal of Dermatology, 1995•Wiley Online LibraryVarious cell stimuli occur via activation of phospholipase A2, which hydrolyses
polyunsaturated fatty acids from the sn‐2 position of membrane phospholipids, resulting in
the formation of polyunsaturated fatty acids and lysophospholipids. The level of
lysophospholipids is determined by the balance between phospholipase A2 activity and the
rate of catabolism of the lysophospholipids. One of the lysophospholipid classes,
lysophosphatidylcholine, has been shown to stimulate certain leucocyte activities which are …
polyunsaturated fatty acids from the sn‐2 position of membrane phospholipids, resulting in
the formation of polyunsaturated fatty acids and lysophospholipids. The level of
lysophospholipids is determined by the balance between phospholipase A2 activity and the
rate of catabolism of the lysophospholipids. One of the lysophospholipid classes,
lysophosphatidylcholine, has been shown to stimulate certain leucocyte activities which are …
Summary
Various cell stimuli occur via activation of phospholipase A2, which hydrolyses polyunsaturated fatty acids from the sn‐2 position of membrane phospholipids, resulting in the formation of polyunsaturated fatty acids and lysophospholipids. The level of lysophospholipids is determined by the balance between phospholipase A2 activity and the rate of catabolism of the lysophospholipids. One of the lysophospholipid classes, lysophosphatidylcholine, has been shown to stimulate certain leucocyte activities which are of importance for the induction and maintenance of inflammation. In addition, it has been demonstrated that phospholipase A2 activity is increased in psoriatic skin.
In the present study, we analysed the levels of lysophosphatidylcholine, by thin layer chromatography, in lesional psoriatic skin, uninvolved psoriatic skin and normal skin. The lysophosphatidylcholine content, expressed as μmol lysophosphatidylcholine/μmol phosphatidylcholine, was 1.55, 0.21 and 0.12% in lesional psoriatic skin, uninvolved psoriatic skin and normal skin, respectively. The level of lysophosphatidylcholine was significantly elevated in lesional compared with uninvolved psoriatic skin (P= 0.004) and normal skin (P= 0.002). The increased lysophosphatidylcholine levels in psoriatic skin indicate that the phospholipase A2 activation is not accompanied by a corresponding increase in the activity of enzymes catabolizing lysoPC.
If present in biologically active concentrations, lysophosphatidylcholine may contribute to the induction and maintenance of the inflammatory and immunological processes occurring in lesional psoriatic skin.
